Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application
- 11 October 2021
- journal article
- editorial
- Published by Elsevier BV in Endocrine Practice
- Vol. 27 (12), 1266-1268
- https://doi.org/10.1016/j.eprac.2021.10.001
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and TreatmentmSystems, 2021
- Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studiesThe Journal of Steroid Biochemistry and Molecular Biology, 2021
- Vitamin D and Its Potential Benefit for the COVID-19 PandemicEndocrine Practice, 2021
- Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19Endocrine Practice, 2021
- Notable Developments for Vitamin D Amid the COVID-19 Pandemic, but Caution Warranted Overall: A Narrative ReviewNutrients, 2021
- GH deficiency and insensitivity in children and adultsReviews in Endocrine and Metabolic Disorders, 2021
- SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levelsPLOS ONE, 2020
- “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”The Journal of Steroid Biochemistry and Molecular Biology, 2020
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”Inflammation Research, 2020
- Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and DeathsNutrients, 2020